Biggest News Aggregation in the World
📰 Bioscience Segment News

Bioscience Segment News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Bioscience Segment. Real-time updates on events, politics, business and more.

Grifols, S.A. (NASDAQ:GRFS) Receives $13.53 Average Price Target from Analysts

Grifols, S.A. (NASDAQ:GRFS – Get Rating) has been given an average rating of “Moderate Buy” by the nine ratings firms that are presently covering the firm, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year target […]
Morgan Stanley Fred Alger Management Susquehanna International Securities Ltd Mercer Global Advisors Inc Grifols Company Profile Geode Capital Management

Grifols (NASDAQ:GRFS) Trading Down 2%

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) were down 2% during mid-day trading on Tuesday . The stock traded as low as $8.54 and last traded at $8.64. Approximately 98,387 shares were traded during mid-day trading, a decline of 89% from the average daily volume of 899,347 shares. The stock had previously closed at […]
Alanb Lancz Associates Inc Grifols Company Profile Gabelli Funds Morgan Stanley Hennion Walsh Asset Management Inc Get Rating

Grifols (NASDAQ:GRFS) Shares Gap Up to $8.61

Grifols, S.A. (NASDAQ:GRFS – Get Rating) shares gapped up prior to trading on Wednesday . The stock had previously closed at $8.61, but opened at $9.20. Grifols shares last traded at $9.10, with a volume of 516,956 shares traded. Wall Street Analysts Forecast Growth Several research firms have commented on GRFS. Barclays raised shares of […]
Morgan Stanley Advisor Group Holdings Inc Quadrant Capital Group Get Rating Financial Advisors Group Holdings

Harris Associates L P Has $21.89 Million Holdings in Grifols, S.A. (NASDAQ:GRFS)

Harris Associates L P increased its stake in Grifols, S.A. (NASDAQ:GRFS – Get Rating) by 47.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,575,400 shares of the biotechnology company’s stock after purchasing an additional 832,800 shares during the period. Harris […]
Gabelli Funds Morgan Stanley Hennion Walsh Asset Management Inc Harris Associates Alanb Lancz Associates Inc Exchange Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Grifols (NASDAQ:GRFS) Trading Down 2%

Shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) fell 2% on Tuesday . The company traded as low as $8.54 and last traded at $8.64. 98,387 shares were traded during mid-day trading, a decline of 89% from the average session volume of 899,347 shares. The stock had previously closed at $8.82. Analyst Ratings Changes A […]
Advisor Group Holdings Inc Morgan Stanley Quadrant Capital Group Get Rating Financial Advisors Group Holdings

Grifols, S.A. (NASDAQ:GRFS) Receives Consensus Rating of "Moderate Buy" from Analysts

Grifols, S.A. (NASDAQ:GRFS – Get Rating) has been given an average rating of “Moderate Buy” by the nine research firms that are covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price objective […]
Norges Bank Morgan Stanley First Trust Advisors Grifols Company Profile Get Rating Marketbeat Ratings

Grifols (NASDAQ:GRFS) Shares Gap Up to $8.34

Grifols, S.A. (NASDAQ:GRFS – Get Rating) gapped up before the market opened on Friday . The stock had previously closed at $8.34, but opened at $8.90. Grifols shares last traded at $8.88, with a volume of 45,725 shares traded. Analysts Set New Price Targets A number of research firms have recently commented on GRFS. Barclays […]
Ronald Blue Trust Inc Quadrant Capital Group Morgan Stanley Grifols Company Profile Susquehanna International Securities Ltd Get Rating

StockNews.com Begins Coverage on Grifols (NASDAQ:GRFS)

StockNews.com began coverage on shares of Grifols (NASDAQ:GRFS – Get Rating) in a research note released on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. GRFS has been the topic of a number of other reports. Morgan Stanley upgraded shares of Grifols from an equal weight rating to an overweight […]
Morgan Stanley First Trust Advisors Jefferies Financial Group Creek Investment Management Inc Get Rating Moderate Buy

Grifols (NASDAQ:GRFS) Now Covered by StockNews.com

StockNews.com started coverage on shares of Grifols (NASDAQ:GRFS – Get Rating) in a research report released on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. GRFS has been the topic of a number of other reports. Barclays upgraded shares of Grifols from an underweight rating to an equal weight rating in […]
First Trust Advisors Jefferies Financial Group Morgan Stanley Norges Bank Get Rating Moderate Buy

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science